Compounds > diphenyleneiodonium
Page last updated: 2024-10-26

diphenyleneiodonium and Osteogenic Sarcoma

diphenyleneiodonium has been researched along with Osteogenic Sarcoma in 1 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Groth, S1
Schulze, M1
Kalthoff, H1
Fändrich, F1
Ungefroren, H1

Other Studies

1 other study available for diphenyleneiodonium and Osteogenic Sarcoma

ArticleYear
Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta. Evidence for oxidative signaling through NADPH oxidase.
    The Journal of biological chemistry, 2005, Sep-30, Volume: 280, Issue:39

    Topics: Biglycan; Carcinoma; Cell Adhesion; Cell Line, Tumor; Cytochalasin D; Enzyme Activation; Enzyme Inhi

2005